LabCorp Begins Offering Exact Sciences’ PreGen-Plus Colorectal Cancer Test

Exact Sciences hopes consultation with FDA on clinical utility trials for the firm's PreGen-Plus colorectal cancer screening assay will help fulfill potential regulatory requirements in the future

More from Archive

More from Medtech Insight